Bioxyne Ltd logo

Bioxyne Ltd (PR8)

Market Closed
7 Aug, 20:00
XFRA XFRA
0. 55
+0.02
+4.0076%
- Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
0 Eps
0.52
Previous Close
Add Transaction
Day Range
0.54 0.55
Year Range
0.03 0.88
Want to track PR8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PR8 closed Friday higher at €0.55, an increase of 4.0076% from Thursday's close, completing a monthly increase of 0.5721% or €0. Over the past 12 months, PR8 stock gained 1,262.5001%.
PR8 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

PR8 Chart

Bioxyne Ltd (PR8) FAQ

What is the stock price today?

The current price is €0.55.

On which exchange is it traded?

Bioxyne Ltd is listed on XFRA.

What is its stock symbol?

The ticker symbol is PR8.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Bioxyne Ltd ever had a stock split?

No, there has never been a stock split.

Bioxyne Ltd Profile

Food Products Industry
Consumer Staples Sector
Mr. Samuel Watson CEO
XFRA Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bioxyne Limited is a dynamic life sciences and consumer health products company with a global reach, including the United Kingdom, Japan, Europe, and Australia. Established in 1998 and headquartered in Sydney, Australia, the company specializes in the manufacture and distribution of a broad range of consumer health products. These include patented probiotics, health supplements, therapeutic goods, and alternative medicines. Bioxyne Limited is deeply committed to enhancing wellness through its diverse product portfolio, which leverages the power of plant-based components and cutting-edge scientific research. The company's operations also extend to the provision of product research and development services and the innovative use of telemedicine through its BLS Clinics platform.

Products and Services

Bioxyne Limited offers an extensive array of products and services designed to promote health and well-being among consumers worldwide:

  • Consumer Health Products: A broad range of products aimed at improving the daily health and wellness of individuals.
  • Patented Probiotics: Including lactobacillus fermentum VRI-003, these are specially designed for gut health and immune support.
  • Health Supplements: A variety of supplements including vitamins, minerals, and other essential nutrients catering to the diverse health needs of the global population.
  • Therapeutic Goods and Alternative Medicines: Products developed to offer therapeutic benefits and alternative health solutions.
  • Wellness Products and Supplements: This includes plant-based wellness products and supplements such as cannabinoids, cannabis extracts, manuka honey, skin care products, and mushroom complexes.
  • Functional Food Products: The company develops functional food products with health-enhancing ingredients, focusing on innovation in the field of dietary supplements.
  • Product Research and Development Services: Bioxyne Limited is engaged in extensive research and development, aiming to bring forward innovative health products and solutions.
  • Telemedicine Services: Through its BLS Clinics, Bioxyne Limited offers telehealth services, catering to the evolving healthcare needs of its customers.
  • Distribution Channels: The company utilizes a combination of online sales, wholesale, and direct sales strategies to reach its customers in the United States, Asia, and other parts of the world.

Contact Information

Address: 50 Clarence Street
Phone: 61 2 9078 8180